The Biodefense Mass Sequencing and Surveillance assay, developed by the Synthetic Biology and Biosurveillance Branch at the U.S. Army Medical Research Institute of Infectious Diseases, combines off-the-shelf polymerase chain reaction instruments with large-scale sample pooling and retooled next-generation DNA sequencing assays to rapidly screen samples to identify infected patients and reduce the risk of disease outbreaks.
| Date Taken: | 10.03.2024 |
| Date Posted: | 10.03.2024 15:07 |
| Photo ID: | 8676531 |
| VIRIN: | 241003-O-SG040-7654 |
| Resolution: | 640x426 |
| Size: | 43.93 KB |
| Location: | FORT DETRICK, MARYLAND, US |
| Web Views: | 4 |
| Downloads: | 2 |
This work, MRDC Prepares High-Throughput Infectious Disease Screening Technology for Commercialization [Image 3 of 3], by Paul Lagasse, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
MRDC Prepares High-Throughput Infectious Disease Screening Technology for Commercialization
No keywords found.
